| Literature DB >> 33514395 |
Yadi Zhou1, Junfei Zhao2,3, Jiansong Fang1, William Martin1, Lang Li4, Ruth Nussinov5,6, Timothy A Chan1,7,8,9,10, Charis Eng1,8,9,10,11, Feixiong Cheng12,13,14.
Abstract
Massive genome sequencing data have inspired new challenges in personalized treatments and facilitated oncological drug discovery. We present a comprehensive database, My Personal Mutanome (MPM), for accelerating the development of precision cancer medicine protocols. MPM contains 490,245 mutations from over 10,800 tumor exomes across 33 cancer types in The Cancer Genome Atlas mapped to 94,563 structure-resolved/predicted protein-protein interaction interfaces ("edgetic") and 311,022 functional sites ("nodetic"), including ligand-protein binding sites and 8 types of protein posttranslational modifications. In total, 8884 survival results and 1,271,132 drug responses are obtained for these mapped interactions. MPM is available at https://mutanome.lerner.ccf.org .Entities:
Keywords: Edgetic; Mutanome; Nodetic; Precision cancer medicine; Protein-protein interaction; Somatic mutations
Mesh:
Year: 2021 PMID: 33514395 PMCID: PMC7845113 DOI: 10.1186/s13059-021-02269-3
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583